Eculizumab: new drug. Nocturnal paroxystic haemoglobinuria: fewer transfusions.
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001803:Blood Transfusion; D017277:Drug Approval; D005060:Europe; D006457:Hemoglobinuria, Paroxysmal / Q000188:drug therapy*; D006801:Humans; D016032:Randomized Controlled Trials as Topic
D000911:Antibodies, Monoclonal